1
|
Mirhadi E, Mashreghi M, Faal Maleki M, Alavizadeh SH, Arabi L, Badiee A, Jaafari MR. Redox-sensitive nanoscale drug delivery systems for cancer treatment. Int J Pharm 2020; 589:119882. [DOI: 10.1016/j.ijpharm.2020.119882] [Citation(s) in RCA: 37] [Impact Index Per Article: 9.3] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/12/2020] [Revised: 09/09/2020] [Accepted: 09/10/2020] [Indexed: 12/19/2022]
|
2
|
Schunk HC, Hernandez DS, Austin MJ, Dhada KS, Rosales AM, Suggs LJ. Assessing the range of enzymatic and oxidative tunability for biosensor design. J Mater Chem B 2020; 8:3460-3487. [PMID: 32159202 PMCID: PMC7219111 DOI: 10.1039/c9tb02666e] [Citation(s) in RCA: 6] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/05/2023]
Abstract
Development of multi-functional materials and biosensors that can achieve an in situ response designed by the user is a current need in the biomaterials field, especially in complex biological environments, such as inflammation, where multiple enzymatic and oxidative signals are present. In the past decade, there has been extensive research and development of materials chemistries for detecting and monitoring enzymatic activity, as well as for releasing therapeutic and diagnostic agents in regions undergoing oxidative stress. However, there has been limited development of materials in the context of enzymatic and oxidative triggers together, despite their closely tied and overlapping mechanisms. With research focusing on enzymatically and oxidatively triggered materials separately, these systems may be inadequate in monitoring the complexity of inflammatory environments, thus limiting in vivo translatability and diagnostic accuracy. The intention of this review is to highlight a variety of enzymatically and oxidatively triggered materials chemistries to draw attention to the range of synthetic tunability available for the construction of novel biosensors with a spectrum of programmed responses. We focus our discussion on several types of macromolecular sensors, generally classified by the causative material response driving ultimate signal detection. This includes sensing based on degradative processes, conformational changes, supramolecular assembly/disassembly, and nanomaterial interactions, among others. We see each of these classes providing valuable tools toward coalescing current gaps in the biosensing field regarding specificity, selectivity, sensitivity, and flexibility in application. Additionally, by considering the materials chemistry of enzymatically and oxidatively triggered biomaterials in tandem, we hope to encourage synthesis of new biosensors that capitalize on their synergistic roles and overlapping mechanisms in inflammatory environments for applications in disease diagnosis and monitoring.
Collapse
Affiliation(s)
- Hattie C Schunk
- Department of Biomedical Engineering, University of Texas at Austin, Austin, TX 78712, USA.
| | | | | | | | | | | |
Collapse
|
3
|
Žid L, Zeleňák V, Girman V, Bednarčík J, Zeleňáková A, Szűcsová J, Hornebecq V, Hudák A, Šuleková M, Váhovská L. Doxorobicin as cargo in a redox-responsive drug delivery system capped with water dispersible ZnS nanoparticles. RSC Adv 2020; 10:15825-15835. [PMID: 35493685 PMCID: PMC9052939 DOI: 10.1039/d0ra02091e] [Citation(s) in RCA: 6] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/05/2020] [Accepted: 04/13/2020] [Indexed: 11/29/2022] Open
Abstract
In this work, we have prepared and investigated a redox-responsive drug delivery system (DDS) based on a porous carrier. Doxorubicin (DOX), a chemotherapy medication for treatment of different kinds of cancer, was used as a model drug in the study. DOX was loaded in ordered hexagonal mesoporous silica SBA-15, a nanoporous material with good biocompatibility, stability, large pore size and specific surface area (SBET = 908 m2 g−1, VP = 0.79 cm3 g−1, d = 5.9 nm) and easy surface modification. To prepare the redox-responsive system, cystamine derivative ligands, with redox active disulphide linkers were grafted onto the surface of SBA-15. To ensure no significant premature release of DOX from the porous system, thioglycolic acid modified ZnS nanoparticles (ZnS–COOH NPs) were used as pore capping agents. The grafted redox-responsive cystamine derivative ligand containing disulphide linkers was bonded by a peptide bond to the thioglycolic acid groups of ZnS–COOH NPs, capping the pores. Once the disulphide bond was cleaved, the ZnS–COOH NPs caps were released and pores were opened to deliver the DOX cargo. The dithiol bond was cleavable by redox active molecules such as dithiothreitol (DTT) or glutathione, the concentration of which in cancer cells is 4 times higher than in healthy cells. The redox release of DOX was studied in two different media, physiological saline solution with DTT and saline without DTT. The prepared DDS proved the concept of redox responsive release. All samples were characterised by powder X-ray diffraction (XRD), transition electron microscopy (TEM), nitrogen adsorption/desorption at 77 K, Fourier-transform infrared spectroscopy (FTIR), thermal analysis and zeta potential measurements. The presence of semiconducting ZnS nanoparticle caps on the pore openings was detected by magnetic measurements using SQUID magnetometry showing that such cargo systems could be monitored using magnetic measurements which opens up the possibilities of using such drug delivery systems as theranostic agents. Redox-responsive drug delivery system was studied. ZnS nanoparticles served as pore capping agent to prevent premature release of anticancer drug. Such cargo can be monitored by magnetic field which opens possibilities its use in theranostics.![]()
Collapse
Affiliation(s)
- Lukáš Žid
- Department of Inorganic Chemistry Faculty of Science
- P. J. Šafárik University
- SK-041 54 Košice
- Slovak Republic
| | - Vladimír Zeleňák
- Department of Inorganic Chemistry Faculty of Science
- P. J. Šafárik University
- SK-041 54 Košice
- Slovak Republic
| | - Vladimír Girman
- Institute of Physics
- P. J. Šafárik University
- 04001 Košice
- Slovakia
| | - Jozef Bednarčík
- Institute of Physics
- P. J. Šafárik University
- 04001 Košice
- Slovakia
| | | | | | | | - Alexander Hudák
- Department of Chemistry
- Biochemistry and Biophysics
- Institute of Pharmaceutical Chemistry
- The University of Veterinary Medicine and Pharmacy in Košice
- Košice 041 81
| | - Monika Šuleková
- Department of Chemistry
- Biochemistry and Biophysics
- Institute of Pharmaceutical Chemistry
- The University of Veterinary Medicine and Pharmacy in Košice
- Košice 041 81
| | - Lucia Váhovská
- Department of Chemistry
- Biochemistry and Biophysics
- Institute of Pharmaceutical Chemistry
- The University of Veterinary Medicine and Pharmacy in Košice
- Košice 041 81
| |
Collapse
|
4
|
Aquib M, Farooq MA, Banerjee P, Akhtar F, Filli MS, Boakye-Yiadom KO, Kesse S, Raza F, Maviah MBJ, Mavlyanova R, Wang B. Targeted and stimuli-responsive mesoporous silica nanoparticles for drug delivery and theranostic use. J Biomed Mater Res A 2019; 107:2643-2666. [PMID: 31390141 DOI: 10.1002/jbm.a.36770] [Citation(s) in RCA: 32] [Impact Index Per Article: 6.4] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/16/2019] [Revised: 07/25/2019] [Accepted: 07/29/2019] [Indexed: 12/13/2022]
Abstract
For cancer therapy, the usefulness of mesoporous silica nanoparticles (MPSNPs) has been widely discussed, likely due to its inorganic nature and excellent structural features. The MPSNPs-based chemotherapeutics have been promisingly delivered to their target sites that help to minimize side effects and improve therapeutic effectiveness. A wide array of studies have been conducted to functionalize drug-loaded MPSNPs using targeting ligands and stimuli-sensitive substances. In addition, anticancer drugs have been precisely delivered to their target sites using MPSNPs, which respond to multi-stimuli. Furthermore, MPSNPs have been extensively tested for their safety and compatibility. The toxicity level of MPSNPs is substantially lower as compared to that of colloidal silica; however, in oxidative stress, they exhibit cytotoxic features. The biocompatibility of MPSNPs can be improved by modifying their surfaces. This article describes the production procedures, functionalization, and applications of biocompatible MPSNPs in drug delivery.
Collapse
Affiliation(s)
- Md Aquib
- Department of Pharmaceutics, School of Pharmacy, China Pharmaceutical University, Nanjing, Jiangsu, People's Republic of China
| | - Muhammad A Farooq
- Department of Pharmaceutics, School of Pharmacy, China Pharmaceutical University, Nanjing, Jiangsu, People's Republic of China
| | - Parikshit Banerjee
- Department of Pharmaceutics, School of Pharmacy, China Pharmaceutical University, Nanjing, Jiangsu, People's Republic of China
| | - Fahad Akhtar
- School of Life Science and Technology, China Pharmaceutical University, Nanjing, Jiangsu, People's Republic of China
| | - Mensura S Filli
- Department of Pharmaceutics, School of Pharmacy, China Pharmaceutical University, Nanjing, Jiangsu, People's Republic of China
| | - Kofi O Boakye-Yiadom
- Department of Pharmaceutics, School of Pharmacy, China Pharmaceutical University, Nanjing, Jiangsu, People's Republic of China
| | - Samuel Kesse
- Department of Pharmaceutics, School of Pharmacy, China Pharmaceutical University, Nanjing, Jiangsu, People's Republic of China
| | - Faisal Raza
- Department of Pharmaceutics, School of Pharmacy, China Pharmaceutical University, Nanjing, Jiangsu, People's Republic of China
| | - Mily B J Maviah
- Department of Pharmaceutics, School of Pharmacy, China Pharmaceutical University, Nanjing, Jiangsu, People's Republic of China
| | - Rukhshona Mavlyanova
- Department of Pharmaceutics, School of Pharmacy, China Pharmaceutical University, Nanjing, Jiangsu, People's Republic of China
| | - Bo Wang
- Department of Pharmaceutics, School of Pharmacy, China Pharmaceutical University, Nanjing, Jiangsu, People's Republic of China
| |
Collapse
|
5
|
Castillo RR, Lozano D, González B, Manzano M, Izquierdo-Barba I, Vallet-Regí M. Advances in mesoporous silica nanoparticles for targeted stimuli-responsive drug delivery: an update. Expert Opin Drug Deliv 2019; 16:415-439. [PMID: 30897978 PMCID: PMC6667337 DOI: 10.1080/17425247.2019.1598375] [Citation(s) in RCA: 99] [Impact Index Per Article: 19.8] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/15/2019] [Accepted: 03/19/2019] [Indexed: 02/07/2023]
Abstract
INTRODUCTION Mesoporous silica nanoparticles (MSNs) are outstanding nanoplatforms for drug delivery. Herein, the most recent advances to turn MSN-based carriers into minimal side effect drug delivery agents are covered. AREAS COVERED This review summarizes the scientific advances dealing with MSNs for targeted and stimuli-responsive drug delivery since 2015. Delivery aspects to diseased tissues together with approaches to obtain smart MSNs able to respond to internal or external stimuli and their applications are here described. Special emphasis is done on the combination of two or more stimuli on the same nanoplatform and on combined drug therapy. EXPERT OPINION The use of MSNs in nanomedicine is a promising research field because they are outstanding platforms for treating different pathologies. This is possible thanks to their structural, chemical, physical and biological properties. However, there are certain issues that should be overcome to improve the suitability of MSNs for clinical applications. All materials must be properly characterized prior to their in vivo evaluation; furthermore, preclinical in vivo studies need to be standardized to demonstrate the MSNs clinical translation potential.
Collapse
Affiliation(s)
- Rafael R. Castillo
- Departamento de Química en Ciencias Farmacéuticas, Unidad de Química Inorgánica y Bionorgánica, Universidad Complutense de Madrid, Plaza Ramón y Cajal s/n, 28040 Madrid, Spain
- Instituto de Investigación Sanitaria Hospital 12 de Octubre (imas12)
- Centro de Investigación Biomédica en Red: Bioingeniería, Biomateriales y Nanomedicina (CIBER-BBN)
| | - Daniel Lozano
- Departamento de Química en Ciencias Farmacéuticas, Unidad de Química Inorgánica y Bionorgánica, Universidad Complutense de Madrid, Plaza Ramón y Cajal s/n, 28040 Madrid, Spain
- Instituto de Investigación Sanitaria Hospital 12 de Octubre (imas12)
- Centro de Investigación Biomédica en Red: Bioingeniería, Biomateriales y Nanomedicina (CIBER-BBN)
| | - Blanca González
- Departamento de Química en Ciencias Farmacéuticas, Unidad de Química Inorgánica y Bionorgánica, Universidad Complutense de Madrid, Plaza Ramón y Cajal s/n, 28040 Madrid, Spain
- Instituto de Investigación Sanitaria Hospital 12 de Octubre (imas12)
- Centro de Investigación Biomédica en Red: Bioingeniería, Biomateriales y Nanomedicina (CIBER-BBN)
| | - Miguel Manzano
- Departamento de Química en Ciencias Farmacéuticas, Unidad de Química Inorgánica y Bionorgánica, Universidad Complutense de Madrid, Plaza Ramón y Cajal s/n, 28040 Madrid, Spain
- Instituto de Investigación Sanitaria Hospital 12 de Octubre (imas12)
- Centro de Investigación Biomédica en Red: Bioingeniería, Biomateriales y Nanomedicina (CIBER-BBN)
| | - Isabel Izquierdo-Barba
- Departamento de Química en Ciencias Farmacéuticas, Unidad de Química Inorgánica y Bionorgánica, Universidad Complutense de Madrid, Plaza Ramón y Cajal s/n, 28040 Madrid, Spain
- Instituto de Investigación Sanitaria Hospital 12 de Octubre (imas12)
- Centro de Investigación Biomédica en Red: Bioingeniería, Biomateriales y Nanomedicina (CIBER-BBN)
| | - María Vallet-Regí
- Departamento de Química en Ciencias Farmacéuticas, Unidad de Química Inorgánica y Bionorgánica, Universidad Complutense de Madrid, Plaza Ramón y Cajal s/n, 28040 Madrid, Spain
- Instituto de Investigación Sanitaria Hospital 12 de Octubre (imas12)
- Centro de Investigación Biomédica en Red: Bioingeniería, Biomateriales y Nanomedicina (CIBER-BBN)
| |
Collapse
|
6
|
Rahikkala A, Pereira SAP, Figueiredo P, Passos MLC, Araújo ARTS, Saraiva MLMFS, Santos HA. Mesoporous Silica Nanoparticles for Targeted and Stimuli-Responsive Delivery of Chemotherapeutics: A Review. ACTA ACUST UNITED AC 2018. [DOI: 10.1002/adbi.201800020] [Citation(s) in RCA: 59] [Impact Index Per Article: 9.8] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/18/2022]
Affiliation(s)
- Antti Rahikkala
- Drug Research Program; Division of Pharmaceutical Chemistry and Technology; Faculty of Pharmacy; University of Helsinki; FI-00014 Helsinki Finland
| | - Sarah A. P. Pereira
- LAQV; REQUIMTE; Departamento de Ciências Químicas; Faculdade de Farmácia; Universidade do Porto; 4050-313 Porto Portugal
| | - Patrícia Figueiredo
- Drug Research Program; Division of Pharmaceutical Chemistry and Technology; Faculty of Pharmacy; University of Helsinki; FI-00014 Helsinki Finland
| | - Marieta L. C. Passos
- LAQV; REQUIMTE; Departamento de Ciências Químicas; Faculdade de Farmácia; Universidade do Porto; 4050-313 Porto Portugal
| | - André R. T. S. Araújo
- LAQV; REQUIMTE; Departamento de Ciências Químicas; Faculdade de Farmácia; Universidade do Porto; 4050-313 Porto Portugal
- Unidade de Investigação para o Desenvolvimento do Interior; Instituto Politécnico da Guarda; 6300-559 Guarda Portugal
| | - M. Lúcia M. F. S. Saraiva
- LAQV; REQUIMTE; Departamento de Ciências Químicas; Faculdade de Farmácia; Universidade do Porto; 4050-313 Porto Portugal
| | - Hélder A. Santos
- Drug Research Program; Division of Pharmaceutical Chemistry and Technology; Faculty of Pharmacy; University of Helsinki; FI-00014 Helsinki Finland
- Helsinki Institute of Life Science (HiLIFE); University of Helsinki; FI-00014 Helsinki Finland
| |
Collapse
|
7
|
Lei Z, Zhang X, Zheng X, Liu S, Xie Z. Porphyrin–ferrocene conjugates for photodynamic and chemodynamic therapy. Org Biomol Chem 2018; 16:8613-8619. [DOI: 10.1039/c8ob02391c] [Citation(s) in RCA: 24] [Impact Index Per Article: 4.0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/14/2022]
Abstract
Porphyrin–ferrocene conjugates were designed and synthesized for photodynamic and chemodynamic therapy.
Collapse
Affiliation(s)
- Zhitao Lei
- College of Environmental and Chemical Engineering
- Yanshan University
- Qinhuangdao
- P. R. China
- State Key Laboratory of Polymer Physics and Chemistry
| | - Xiaoyu Zhang
- College of Environmental and Chemical Engineering
- Yanshan University
- Qinhuangdao
- P. R. China
| | - Xiaohua Zheng
- State Key Laboratory of Polymer Physics and Chemistry
- Changchun Institute of Applied Chemistry
- Chinese Academy of Sciences
- Changchun 130022
- P. R. China
| | - Shi Liu
- State Key Laboratory of Polymer Physics and Chemistry
- Changchun Institute of Applied Chemistry
- Chinese Academy of Sciences
- Changchun 130022
- P. R. China
| | - Zhigang Xie
- State Key Laboratory of Polymer Physics and Chemistry
- Changchun Institute of Applied Chemistry
- Chinese Academy of Sciences
- Changchun 130022
- P. R. China
| |
Collapse
|
8
|
Saravanakumar G, Kim J, Kim WJ. Reactive-Oxygen-Species-Responsive Drug Delivery Systems: Promises and Challenges. ADVANCED SCIENCE (WEINHEIM, BADEN-WURTTEMBERG, GERMANY) 2017; 4:1600124. [PMID: 28105390 PMCID: PMC5238745 DOI: 10.1002/advs.201600124] [Citation(s) in RCA: 410] [Impact Index Per Article: 58.6] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Subscribe] [Scholar Register] [Received: 03/30/2016] [Revised: 04/26/2016] [Indexed: 05/19/2023]
Abstract
Given the increasing evidence indicates that many pathological conditions are associated with elevated reactive oxygen species (ROS) levels, there have been growing research efforts focused on the development of ROS-responsive carrier systems because of their promising potential to realize more specific diagnosis and effective therapy. By judicious utilization of ROS-responsive functional moieties, a wide range of carrier systems has been designed for ROS-mediated drug delivery. In this review article, insights into design principle and recent advances on the development of ROS-responsive carrier systems for drug delivery applications are provided alongside discussion of their in vitro and in vivo evaluation. In particular, the discussions in this article will mainly focus on polymeric nanoparticles, hydrogels, inorganic nanoparticles, and activatable prodrugs that have been integrated with diverse ROS-responsive moieties for spatiotemporally controlled release of drugs for effective therapy.
Collapse
Affiliation(s)
- Gurusamy Saravanakumar
- Center for Self‐Assembly and ComplexityInstitute for Basic Science (IBS)Pohang37673Republic of Korea
| | - Jihoon Kim
- Center for Self‐Assembly and ComplexityInstitute for Basic Science (IBS)Pohang37673Republic of Korea
| | - Won Jong Kim
- Center for Self‐Assembly and ComplexityInstitute for Basic Science (IBS)Pohang37673Republic of Korea
- Department of ChemistryPohang University of Science and Technology (POSTECH)Pohang37673Republic of Korea
| |
Collapse
|
9
|
Kumari V, Chatterjee N, Das S, Bhunia S, Saha KD, Bhaumik A. Self-assembled ZnS nanospheres with nanoscale porosity as an efficient carrier for the delivery of doxorubicin. RSC Adv 2015. [DOI: 10.1039/c5ra17998j] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/21/2022] Open
Abstract
Self-aggregated mesoporous ZnS nanomaterials have been utilized as a drug-delivery vehicle that can activates the apoptotic pathway with a minimal concentration of doxorubicin and it can regulates lymphocytic leukemia cell growth.
Collapse
Affiliation(s)
- Vandana Kumari
- Department of Material Science
- Institution Association for the Cultivation of Science
- Kolkata-700032
- India
| | - Nabanita Chatterjee
- Cancer Biology and Inflammatory Disorder Division
- CSIR-Indian Institute of Chemical Biology
- Kolkata-700032
- India
| | - Subhadip Das
- Cancer Biology and Inflammatory Disorder Division
- CSIR-Indian Institute of Chemical Biology
- Kolkata-700032
- India
| | - Subhajit Bhunia
- Department of Material Science
- Institution Association for the Cultivation of Science
- Kolkata-700032
- India
| | - Krishna Das Saha
- Cancer Biology and Inflammatory Disorder Division
- CSIR-Indian Institute of Chemical Biology
- Kolkata-700032
- India
| | - Asim Bhaumik
- Department of Material Science
- Institution Association for the Cultivation of Science
- Kolkata-700032
- India
| |
Collapse
|
10
|
Kankala RK, Kuthati Y, Liu CL, Mou CY, Lee CH. Killing cancer cells by delivering a nanoreactor for inhibition of catalase and catalytically enhancing intracellular levels of ROS. RSC Adv 2015. [DOI: 10.1039/c5ra16023e] [Citation(s) in RCA: 53] [Impact Index Per Article: 5.9] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/22/2023] Open
Abstract
Intracellular hydrogen peroxide levels have the potential to be exploited in cancer therapy.
Collapse
Affiliation(s)
- Ranjith Kumar Kankala
- Department of Life Science and Institute of Biotechnology
- National Dong Hwa University
- Hualien
- Taiwan
| | - Yaswanth Kuthati
- Department of Life Science and Institute of Biotechnology
- National Dong Hwa University
- Hualien
- Taiwan
| | - Chen-Lun Liu
- Department of Life Science and Institute of Biotechnology
- National Dong Hwa University
- Hualien
- Taiwan
| | - Chung-Yuan Mou
- Department of Chemistry
- National Taiwan University
- Taipei 106
- Taiwan
| | - Chia-Hung Lee
- Department of Life Science and Institute of Biotechnology
- National Dong Hwa University
- Hualien
- Taiwan
| |
Collapse
|